Treatment Outcomes for Childhood Acute Lymphoblastic Leukemia in Resource-Limited Settings: A Hybrid Risk-Stratified Treatment Protocol Without Minimal Residual Disease Measurement

被引：0
|
作者：
Alsakka, Suzan [1 ]
Jneidi, Safaa [1 ]
Ghanem, Khaled [1 ]
机构：
[1] BASMA Pediat Oncol Unit, Damascus, Syria
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
ALL; children; low income; MRD;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ALL-572
引用
收藏
页码：S276 / S276
页数：1
相关论文
共 50 条
  • [21] Modelling a minimal residual disease-based treatment strategy in childhood acute lymphoblastic leukaemia
    Campbell, PJ
    Morley, AA
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (01) : 30 - 38
  • [22] Real World Treatment Outcomes of Patients with Acute Lymphoblastic Leukemia Treated with the PETHEMA ALLHR11 Protocol, Emphasis on Minimal Residual Disease and Survival
    Camargo, Carmenza
    Victoria Herrera, Maria
    Solano-Vega, Julio
    Margarita Rojas, Silvia
    Cordoba, Iris
    Heider, Ulrike
    Parra, Norma
    Sanchez, Paula
    Arevalo, Diego
    Sandoval, Gisella
    Munoz, Stephania
    Arevalo-Zambrano, Monica
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S197 - S198
  • [23] Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia
    Ceppi, Francesco
    Rizzati, Frida
    Colombini, Antonella
    Conter, Valentino
    Cazzaniga, Giovanni
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (09) : 795 - 807
  • [24] TREATMENT OF MINIMAL RESIDUAL DISEASE IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - THE GERMAN NATIONAL STUDY
    HOELZER, D
    THIEL, E
    LOFFLER, H
    BUCHNER, T
    BODENSTEIN, D
    ENGELHARDT, R
    RUHL, H
    GANSER, A
    ZWINGERS, T
    MESSERER, D
    LEUKEMIA RESEARCH, 1986, 10 (01) : 89 - 89
  • [25] Effect of Risk-Stratified Therapy on Health Status and Sociodemographic Outcomes in Survivors of Acute Lymphoblastic Leukemia (ALL) in the Childhood Cancer Survivor Study
    Dixon, S.
    Chen, Y.
    Yasui, Y.
    Pui, C. H.
    Hunger, S.
    Silverman, L.
    Green, D.
    Kadan-Lottick, N.
    Ness, K.
    Leisenring, W.
    Howell, R.
    Oeffinger, K.
    Neglia, J.
    Krull, K.
    Hudson, M.
    Robison, L.
    Mertens, A.
    Armstrong, G.
    Nathan, P.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S40 - S41
  • [26] A prospective evaluation of minimal residual disease as risk stratification for CCLG-ALL-2008 treatment protocol in pediatric B precursor acute lymphoblastic leukemia
    Hu, Y. -X.
    Lu, J.
    He, H. -L.
    Wang, Y.
    Li, J. -Q.
    Xiao, P. -F.
    Li, J.
    Lv, H.
    Sun, Y. -N.
    Fan, J. -J.
    Chai, Y. -H.
    Hu, S. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (09) : 1680 - 1690
  • [27] Implementation of An Aggressive Risk Stratified Treatment Protocol for Children and Adolescents with Acute Lymphoblastic Leukemia in a Developing Country
    Muwakkit, Samar A.
    Al-Aridi, Carol
    Samra, Ahmad
    Saab, Raya
    Mahfouz, Ram
    Farra, Chantal
    Jeha, Sima
    Abboud, Miguel R.
    BLOOD, 2011, 118 (21) : 399 - 400
  • [28] Implementation of a risk stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia (ALL) in a developing country
    Abboud, Miguel R.
    Samra, Ahmad
    Khalifeh, Hassan
    Noun, Peter
    Mahfouz, Rami
    Jena, Sima
    Razzouk, Bassem
    Ribeiro, Raul
    Muwakitt, Samar
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 456 - 456
  • [29] Cognitive Outcomes Following Contemporary Treatment Without Cranial Irradiation for Childhood Acute Lymphoblastic Leukemia
    Conklin, H. M.
    Krull, K. R.
    Reddick, W. E.
    Pei, D.
    Cheng, C.
    Pui, C. H.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (18): : 1386 - 1395
  • [30] Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia
    Zhang, Hui
    Liu, Anthony Pak-Yin
    Devidas, Meenakshi
    Lee, Shawn H. R.
    Cao, Xueyuan
    Pei, Deqing
    Borowitz, Michael
    Wood, Brent
    Gastier-Foster, Julie M.
    Dai, Yunfeng
    Raetz, Elizabeth
    Larsen, Eric
    Winick, Naomi
    Bowman, W. Paul
    Karol, Seth
    Yang, Wenjian
    Martin, Paul L.
    Carroll, William L.
    Pui, Ching-Hon
    Mullighan, Charles G.
    Evans, William E.
    Cheng, Cheng
    Hunger, Stephen P.
    Relling, Mary, V
    Loh, Mignon L.
    Yang, Jun J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (04): : 408 - 417
12345